1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Drug Modelling Software Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Drug Modelling Software Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Drug Modelling Software Market Regional Analysis
6.2 Europe Drug Modelling Software Market Revenue 2017-2027 (US$ Million)
6.3 Europe Drug Modelling Software Market Forecast Analysis
7. Europe Drug Modelling Software Market Analysis – by Product Type
7.1 Database
- 7.1.1 Overview
- 7.1.2 Database: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Software
- 7.2.1 Overview
- 7.2.2 Software: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Drug Modelling Software Market Analysis – by Application
8.1 Drug Discovery and Development
- 8.1.1 Overview
- 8.1.2 Drug Discovery and Development: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Computational Physiological Medicine
- 8.2.1 Overview
- 8.2.2 Computational Physiological Medicine: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Disease Modelling
- 8.3.1 Overview
- 8.3.2 Disease Modelling: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Medical Imaging
- 8.4.1 Overview
- 8.4.2 Medical Imaging: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Predictive Analysis of Drug Targets
- 8.5.1 Overview
- 8.5.2 Predictive Analysis of Drug Targets: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.6 Simulation Software
- 8.6.1 Overview
- 8.6.2 Simulation Software: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.7 Cellular Simulation
- 8.7.1 Overview
- 8.7.2 Cellular Simulation: Europe Drug Modelling Software Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Drug Modelling Software Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Drug Modelling Software Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Europe Drug Modelling Software Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.1.2 UK: Europe Drug Modelling Software Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.2.2 Germany: Europe Drug Modelling Software Market Breakdown, by Application
- 9.2.1.3 France:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.3.2 France: Europe Drug Modelling Software Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.4.2 Russia: Europe Drug Modelling Software Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.5.2 Italy: Europe Drug Modelling Software Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Drug Modelling Software Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Drug Modelling Software Market Breakdown, by Product Type
- 9.2.1.6.2 Rest of Europe: Europe Drug Modelling Software Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Crown Bioscience Inc (JSR life science)
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Genedata AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Biognos AB
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Dassault Systèmes
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Acellera
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Europe Drug Modelling Software Market
